This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Anti-microbial/Anti-fungal Tests Market

Market Insights on Anti-microbial/Anti-fungal Tests covering sales outlook, demand forecast & up-to-date key trends

Anti-microbial/Anti-fungal Tests Market By Test Types (Molecular Based Tests, Phenotypic Resistance Tests, Complex Test Panels, Mass Spectrometry, Rapid Diagnostic Tests), End User (Hospitals, Ambulatory Surgical Centers, Clinics, Community Health Centers), Type (Antimicrobial Resistance, Microbial Infection) & Region - Forecast 2017 - 2027

Local Governments Entering into Partnerships with Manufacturers in Anti-microbial/Anti-fungal Tests Market

Government partnerships and tendering between diagnostic kit manufacturers is poised to provide manufacturers with substantial long-term opportunities in the anti-microbial/ anti-fungal tests market.

Governments in Latin American and Asian countries are working overtime to eradicate highly infectious diseases by providing free medication and diagnostic tests to their underprivileged citizens through government-backed programs. In order to achieve these objectives, local authorities need a constant supply of diagnostic kits and manufacture tendering or partnerships are the best solution to this.

Partnership / tendering benefits manufacturers as it provides them with a stable revenue stream for a specific period of time. Emerging economies such as India and Brazil have favourable opportunities for tendering and this is expected to boost the anti-microbial/ anti-fungal tests market over the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Companies Strengthening Distribution Channels to Target All End Users in Anti-microbial/Anti-fungal Tests Market

At present, companies in the anti-microbial/ anti-fungal tests market are investing in their distribution networks to increase their sales in untapped markets. An effective way to do so is through strategic partnerships and alliances with local suppliers. These partnerships have proven to be critically important to manufacturers because they provide an edge over the competition and allow companies to introduce their products into niche markets, increasing their user base.

Anti-microbial/Anti-fungal Tests Market Download Report Brochure

Hospitals are predicted to be the largest end-user in the global anti-microbial/ anti-fungal tests market for the foreseeable future and should push past US$ 1.2 billion by end 2027.

Lack of Innovation Culture a Challenge to Overcome in the Anti-microbial/Anti-Fungal Tests Market

Healthcare providers and medical personnel in general tend to be risk averse and extremely hesitant to change any policies or procedures. There have been several instances in the field of in-vitro diagnostics where physicians have been resistant to change if the impending innovation is likely to reduce the organizational income stream. The management and organization of diagnostic services can further exacerbate this problem.

This constraint is felt even more acutely in emerging economies where innovations performed and maintained by well-funded labs do not work in resource-starved healthcare facilities in far-flung rural areas. Therefore, companies would do well to focus on the hospital segment of the APEJ anti-microbial/ anti-fungal tests market as it is anticipated to push past US$ 250 million in 2027.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Quality Education and Training Need of the Hour in the Anti-microbial/Anti-fungal Tests Market

For a seamless transition of molecular diagnostics from a lab to a clinic, extensive optimization is required to interpret the results accurately. Diagnostic and clinical labs need highly skilled professionals who are experts in the medical and healthcare field. Unfortunately, limited resources in emerging economies mean that they can allocate only a sliver of public funds to clinical labs and an even smaller percentage of this to quality assurance.

Well-trained personnel are absolutely essential and are in short supply in the 21st century. A WHO report states that Sub-Saharan Africa has an acute healthcare crisis with only 168 medical schools in 47 countries.

In Sub-Saharan Africa, 11 countries do not have a single medical school while 24 have only one. Although hospitals are the largest end-user in MEA anti-microbial/ anti-fungal tests market, the reference laboratory segment is projected to witness a higher CAGR of 5.6% from 2017 to 2027.

Anti-Microbial/Anti-Fungal Tests Market Taxonomy

Test Types:

  • Molecular Based Tests
    • PCR Test
    • DNA Microarray
  • Phenotypic Resistance Tests
  • Complex Test Panels
  • Mass Spectrometry
  • Rapid Diagnostic Tests
    • E-Test Antibiotic/Antifungal Strips
    • Biosensor Platforms

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Community Health Centers
  • Reference Laboratories

Type:

  • Antimicrobial Resistance
    • Methicillin-Resistant Staphylococcus Aureus
    • Vancomycin-Resistant Enterococcus
    • Multi-Drug-Resistant Mycobacterium tuberculosis
    • Carbapenem-Resistant Enterobacteriaceae gut bacteria
  • Microbial Infection
  • Antifungal Resistance
    • Candida infections
    • Aspergillus infection
    • Fusariosis
    • Others
  • Fungal Infection

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Table of Content

1. Executive Summary

1.1. Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Anti-Microbial/Anti-Fungal Tests Market View Point Analysis 

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Key Regulations

4. North America Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

4.5.1. Molecular Based Tests

4.5.1.1. PCR Test

4.5.1.2. DNA Microarray

4.5.2. Phenotypic Resistance Tests

4.5.3. Complex Test Panels

4.5.4. Mass Spectrometry

4.5.5. Rapid Diagnostic Tests

4.5.5.1. E-Test Antibiotic/Antifungal Strips

4.5.5.2. Biosensor Platforms

4.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

4.6.1. Molecular Based Tests

4.6.1.1. PCR Test

4.6.1.2. DNA Microarray

4.6.2. Phenotypic Resistance Tests

4.6.3. Complex Test Panels

4.6.4. Mass Spectrometry

4.6.5. Rapid Diagnostic Tests

4.6.5.1. E-Test Antibiotic/Antifungal Strips

4.6.5.2. Biosensor Platforms

4.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

4.7.1. Anti-microbial Resistance

4.7.2. Microbial Infection

4.7.3. Anti-fungal Resistance

4.7.4. Fungal Infection

4.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

4.8.1. Anti-microbial Resistance

4.8.2. Microbial Infection

4.8.3. Anti-fungal Resistance

4.8.4. Fungal Infection

4.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

4.9.1. Hospitals

4.9.2. Ambulatory Surgical Centers

4.9.3. Clinics

4.9.4. Community Health Centers

4.9.5. Reference Laboratories

4.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

4.10.1.  Hospitals

4.10.2.  Ambulatory Surgical Centers

4.10.3.  Clinics

4.10.4.  Community Health Centers

4.10.5.  Reference Laboratories

4.11. Market Attractiveness Analysis

4.11.1.  By Country

4.11.2.  By Test Type

4.11.3.  By Infection Type 

4.11.4.  By End User

4.12. Intensity Mapping

5. Latin America Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Rest of Latin America

5.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

5.5.1. Molecular Based Tests

5.5.1.1. PCR Test

5.5.1.2. DNA Microarray

5.5.2. Phenotypic Resistance Tests

5.5.3. Complex Test Panels

5.5.4. Mass Spectrometry

5.5.5. Rapid Diagnostic Tests

5.5.5.1. E-Test Antibiotic/Antifungal Strips

5.5.5.2. Biosensor Platforms

5.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

5.6.1. Molecular Based Tests

5.6.1.1. PCR Test

5.6.1.2. DNA Microarray

5.6.2. Phenotypic Resistance Tests

5.6.3. Complex Test Panels

5.6.4. Mass Spectrometry

5.6.5. Rapid Diagnostic Tests

5.6.5.1. E-Test Antibiotic/Antifungal Strips

5.6.5.2. Biosensor Platforms

5.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

5.7.1. Anti-microbial Resistance

5.7.2. Microbial Infection

5.7.3. Anti-fungal Resistance

5.7.4. Fungal Infection

5.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

5.8.1. Anti-microbial Resistance

5.8.2. Microbial Infection

5.8.3. Anti-fungal Resistance

5.8.4. Fungal Infection

5.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

5.9.1. Hospitals

5.9.2. Ambulatory Surgical Centers

5.9.3. Clinics

5.9.4. Community Health Centers

5.9.5. Reference Laboratories

5.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

5.10.1.  Hospitals

5.10.2.  Ambulatory Surgical Centers

5.10.3.  Clinics

5.10.4.  Community Health Centers

5.10.5.  Reference Laboratories

5.11. Market Attractiveness Analysis

5.11.1.  By Country

5.11.2.  By Test Type

5.11.3.  By Infection Type 

5.11.4.  By End User

5.12. Intensity Mapping

6. Western Europe Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

6.3.1. Germany

6.3.2. United Kingom

6.3.3. France

6.3.4. Italy

6.3.5. Spain

6.3.6. Nordic Region

6.3.7. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

6.4.1. Germany

6.4.2. United Kingom

6.4.3. France

6.4.4. Italy

6.4.5. Spain

6.4.6. Nordic Region

6.4.7. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

6.5.1. Molecular Based Tests

6.5.1.1. PCR Test

6.5.1.2. DNA Microarray

6.5.2. Phenotypic Resistance Tests

6.5.3. Complex Test Panels

6.5.4. Mass Spectrometry

6.5.5. Rapid Diagnostic Tests

6.5.5.1. E-Test Antibiotic/Antifungal Strips

6.5.5.2. Biosensor Platforms

6.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

6.6.1. Molecular Based Tests

6.6.1.1. PCR Test

6.6.1.2. DNA Microarray

6.6.2. Phenotypic Resistance Tests

6.6.3. Complex Test Panels

6.6.4. Mass Spectrometry

6.6.5. Rapid Diagnostic Tests

6.6.5.1. E-Test Antibiotic/Antifungal Strips

6.6.5.2. Biosensor Platforms

6.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

6.7.1. Anti-microbial Resistance

6.7.2. Microbial Infection

6.7.3. Anti-fungal Resistance

6.7.4. Fungal Infection

6.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

6.8.1. Anti-microbial Resistance

6.8.2. Microbial Infection

6.8.3. Anti-fungal Resistance

6.8.4. Fungal Infection

6.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

6.9.1. Hospitals

6.9.2. Ambulatory Surgical Centers

6.9.3. Clinics

6.9.4. Community Health Centers

6.9.5. Reference Laboratories

6.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

6.10.1.  Hospitals

6.10.2.  Ambulatory Surgical Centers

6.10.3.  Clinics

6.10.4.  Community Health Centers

6.10.5.  Reference Laboratories

6.11. Market Attractiveness Analysis

6.11.1.  By Country

6.11.2.  By Test Type

6.11.3.  By Infection Type 

6.11.4.  By End User

6.12. Intensity Mapping

7. Eastern Europe Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

7.5.1. Molecular Based Tests

7.5.1.1. PCR Test

7.5.1.2. DNA Microarray

7.5.2. Phenotypic Resistance Tests

7.5.3. Complex Test Panels

7.5.4. Mass Spectrometry

7.5.5. Rapid Diagnostic Tests

7.5.5.1. E-Test Antibiotic/Antifungal Strips

7.5.5.2. Biosensor Platforms

7.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

7.6.1. Molecular Based Tests

7.6.1.1. PCR Test

7.6.1.2. DNA Microarray

7.6.2. Phenotypic Resistance Tests

7.6.3. Complex Test Panels

7.6.4. Mass Spectrometry

7.6.5. Rapid Diagnostic Tests

7.6.5.1. E-Test Antibiotic/Antifungal Strips

7.6.5.2. Biosensor Platforms

7.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

7.7.1. Anti-microbial Resistance

7.7.2. Microbial Infection

7.7.3. Anti-fungal Resistance

7.7.4. Fungal Infection

7.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

7.8.1. Anti-microbial Resistance

7.8.2. Microbial Infection

7.8.3. Anti-fungal Resistance

7.8.4. Fungal Infection

7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

7.9.1. Hospitals

7.9.2. Ambulatory Surgical Centers

7.9.3. Clinics

7.9.4. Community Health Centers

7.9.5. Reference Laboratories

7.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

7.10.1.  Hospitals

7.10.2.  Ambulatory Surgical Centers

7.10.3.  Clinics

7.10.4.  Community Health Centers

7.10.5.  Reference Laboratories

7.11. Market Attractiveness Analysis

7.11.1.  By Country

7.11.2.  By Test Type

7.11.3.  By Infection Type 

7.11.4.  By End User

7.12. Intensity Mapping

8. Asia Pacific excluding Japan Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

8.3.1. China

8.3.2. India

8.3.3. Australia and New Zealand

8.3.4. ASEAN

8.3.5. Rest of Asia Pacific excluding Japan

8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

8.4.1. China

8.4.2. India

8.4.3. Australia and New Zealand

8.4.4. ASEAN

8.4.5. Rest of Asia Pacific excluding Japan

8.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

8.5.1. Molecular Based Tests

8.5.1.1. PCR Test

8.5.1.2. DNA Microarray

8.5.2. Phenotypic Resistance Tests

8.5.3. Complex Test Panels

8.5.4. Mass Spectrometry

8.5.5. Rapid Diagnostic Tests

8.5.5.1. E-Test Antibiotic/Antifungal Strips

8.5.5.2. Biosensor Platforms

8.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

8.6.1. Molecular Based Tests

8.6.1.1. PCR Test

8.6.1.2. DNA Microarray

8.6.2. Phenotypic Resistance Tests

8.6.3. Complex Test Panels

8.6.4. Mass Spectrometry

8.6.5. Rapid Diagnostic Tests

8.6.5.1. E-Test Antibiotic/Antifungal Strips

8.6.5.2. Biosensor Platforms

8.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

8.7.1. Anti-microbial Resistance

8.7.2. Microbial Infection

8.7.3. Anti-fungal Resistance

8.7.4. Fungal Infection

8.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

8.8.1. Anti-microbial Resistance

8.8.2. Microbial Infection

8.8.3. Anti-fungal Resistance

8.8.4. Fungal Infection

8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

8.9.1. Hospitals

8.9.2. Ambulatory Surgical Centers

8.9.3. Clinics

8.9.4. Community Health Centers

8.9.5. Reference Laboratories

8.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

8.10.1.  Hospitals

8.10.2.  Ambulatory Surgical Centers

8.10.3.  Clinics

8.10.4.  Community Health Centers

8.10.5.  Reference Laboratories

8.11. Market Attractiveness Analysis

8.11.1.  By Country

8.11.2.  By Test Type

8.11.3.  By Infection Type 

8.11.4.  By End User

8.12. Intensity Mapping

9. Japan Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

9.3.1. Molecular Based Tests

9.3.1.1. PCR Test

9.3.1.2. DNA Microarray

9.3.2. Phenotypic Resistance Tests

9.3.3. Complex Test Panels

9.3.4. Mass Spectrometry

9.3.5. Rapid Diagnostic Tests

9.3.5.1. E-Test Antibiotic/Antifungal Strips

9.3.5.2. Biosensor Platforms

9.4. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

9.4.1. Molecular Based Tests

9.4.1.1. PCR Test

9.4.1.2. DNA Microarray

9.4.2. Phenotypic Resistance Tests

9.4.3. Complex Test Panels

9.4.4. Mass Spectrometry

9.4.5. Rapid Diagnostic Tests

9.4.5.1. E-Test Antibiotic/Antifungal Strips

9.4.5.2. Biosensor Platforms

9.5. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

9.5.1. Anti-microbial Resistance

9.5.2. Microbial Infection

9.5.3. Anti-fungal Resistance

9.5.4. Fungal Infection

9.6. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

9.6.1. Anti-microbial Resistance

9.6.2. Microbial Infection

9.6.3. Anti-fungal Resistance

9.6.4. Fungal Infection

9.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

9.7.1. Hospitals

9.7.2. Ambulatory Surgical Centers

9.7.3. Clinics

9.7.4. Community Health Centers

9.7.5. Reference Laboratories

9.8. Market Size (US$ Mn) Forecast By End User, 2017–2027

9.8.1. Hospitals

9.8.2. Ambulatory Surgical Centers

9.8.3. Clinics

9.8.4. Community Health Centers

9.8.5. Reference Laboratories

9.9. Market Attractiveness Analysis

9.9.1. By Test Type

9.9.2. By Infection Type 

9.9.3. By End User

9.10. Intensity Mapping

10. Middle East & Africa Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1.  Drivers

10.2.2.  Restraints

10.2.3.  Trends

10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

10.3.1.  GCC Countries

10.3.2.  South Africa

10.3.3.  Rest of Middle East and Africa

10.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

10.4.1.  GCC Countries

10.4.2.  South Africa

10.4.3.  Rest of Middle East and Africa

10.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

10.5.1.  Molecular Based Tests

10.5.1.1. PCR Test

10.5.1.2. DNA Microarray

10.5.2.  Phenotypic Resistance Tests

10.5.3.  Complex Test Panels

10.5.4.  Mass Spectrometry

10.5.5.  Rapid Diagnostic Tests

10.5.5.1. E-Test Antibiotic/Antifungal Strips

10.5.5.2. Biosensor Platforms

10.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

10.6.1.  Molecular Based Tests

10.6.1.1. PCR Test

10.6.1.2. DNA Microarray

10.6.2.  Phenotypic Resistance Tests

10.6.3.  Complex Test Panels

10.6.4.  Mass Spectrometry

10.6.5.  Rapid Diagnostic Tests

10.6.5.1. E-Test Antibiotic/Antifungal Strips

10.6.5.2. Biosensor Platforms

10.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

10.7.1.  Anti-microbial Resistance

10.7.2.  Microbial Infection

10.7.3.  Anti-fungal Resistance

10.7.4.  Fungal Infection

10.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

10.8.1.  Anti-microbial Resistance

10.8.2.  Microbial Infection

10.8.3.  Anti-fungal Resistance

10.8.4.  Fungal Infection

10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

10.9.1.  Hospitals

10.9.2.  Ambulatory Surgical Centers

10.9.3.  Clinics

10.9.4.  Community Health Centers

10.9.5.  Reference Laboratories

10.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

10.10.1. Hospitals

10.10.2. Ambulatory Surgical Centers

10.10.3. Clinics

10.10.4. Community Health Centers

10.10.5. Reference Laboratories

10.11. Market Attractiveness Analysis

10.11.1. By Country

10.11.2. By Test Type

10.11.3. By Infection Type 

10.11.4. By End User

10.12. Intensity Mapping

11. Forecast Factors: Relevance and Impact

12. Competition Landscape

12.1. Market Structure

12.2. Competition Dashboard

12.3. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

12.3.1.  Abbott Laboratories 

12.3.2.  bioMérieux SA 

12.3.3.  Bio-Rad Laboratories Inc. 

12.3.4.  Bruker Corporation 

12.3.5.  Danaher Corporation

12.3.6.  Erba Mannheim

12.3.7.  F. Hoffmann-La Roche AG 

12.3.8.  Luminex Corporation 

12.3.9.  Meridian Bioscience Inc. 

12.3.10. Norgen Biotek Corp. 

12.3.11. Omega Diagnostics Group Plc. 

12.3.12. Qiagen N.V. 

12.3.13. Quidel Corporation

12.3.14. Thermo Fisher Scientific Inc.

13. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Region

13.1. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016

13.1.1.  North America

13.1.2.  Latin America

13.1.3.  Western Europe

13.1.4.  Eastern Europe

13.1.5.  Asia Pacific excluding Japan

13.1.6.  Japan

13.1.7.  Middle East & Africa

13.2. Market Size (US$ Mn) Forecast By Region, 2017–2027

13.2.1.  North America

13.2.2.  Latin America

13.2.3.  Western Europe

13.2.4.  Eastern Europe

13.2.5.  Asia Pacific excluding Japan

13.2.6.  Japan

13.2.7.  Middle East & Africa

13.3. Market Attractiveness Analysis By Region

14. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Test Type 

14.1. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016

14.1.1.  Molecular Based Tests

14.1.1.1. PCR Test

14.1.1.2. DNA Microarray

14.1.2.  Phenotypic Resistance Tests

14.1.3.  Complex Test Panels

14.1.4.  Mass Spectrometry

14.1.5.  Rapid Diagnostic Tests

14.1.5.1. E-Test Antibiotic/Antifungal Strips

14.1.5.2. Biosensor Platforms

14.2. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027

14.2.1.  Molecular Based Tests

14.2.1.1. PCR Test

14.2.1.2. DNA Microarray

14.2.2.  Phenotypic Resistance Tests

14.2.3.  Complex Test Panels

14.2.4.  Mass Spectrometry

14.2.5.  Rapid Diagnostic Tests

14.2.5.1. E-Test Antibiotic/Antifungal Strips

14.2.5.2. Biosensor Platforms

14.3. Market Attractiveness Analysis By Test Type

15. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2015 and Forecast 2017–2027, By Infection Type

15.1. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016

15.1.1.  Anti-microbial Resistance

15.1.2.  Microbial Infection

15.1.3.  Anti-fungal Resistance

15.1.4.  Fungal Infection

15.2. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027

15.2.1.  Anti-microbial Resistance

15.2.2.  Microbial Infection

15.2.3.  Anti-fungal Resistance

15.2.4.  Fungal Infection

15.3. Market Attractiveness Analysis By Infection Type

16. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By End User

16.1. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

16.1.1. Hospitals

16.1.2. Ambulatory Surgical Centers

16.1.3. Clinics

16.1.4. Community Health Centers

16.1.5. Reference Laboratories

16.2. Market Size (US$ Mn) Forecast By End User, 2017–2027

16.2.1. Hospitals

16.2.2. Ambulatory Surgical Centers

16.2.3. Clinics

16.2.4. Community Health Centers

16.2.5. Reference Laboratories

16.3.Market Attractiveness Analysis By End User

17. Assumptions and Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type

Table 03: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type

Table 04: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 05: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 06: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type

Table 07: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type

Table 08: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 09: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 10: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type

Table 11: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type

Table 12: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 13: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 14: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type

Table 15: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type

Table 16: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 17: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 18: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type

Table 19: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type

Table 20: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 21: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type

Table 22: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type

Table 23: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 24: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 25: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type

Table 26: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type

Table 27: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 28: Global Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Region

Table 29: Global Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type

Table 30: Global Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type

Table 31: Global Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Anti-microbial/Anti-fungal Tests Market Revenue Share by Test Type, 2017E & 2027F

Figure 2: Anti-microbial/Anti-fungal Tests Market Revenue Share by Infection Type, 2017E & 2027F

Figure 3: Anti-microbial/Anti-fungal Tests Market Revenue Share by End User, 2017E & 2027F

Figure 4: North America Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)

Figure 5: North America Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)

Figure 6: North America Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)

Figure 7: North America Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)

Figure 8: North America Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 9: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 10: U.S. Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 11: Canada Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 12: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027

Figure 13: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027

Figure 14: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027

Figure 15: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027

Figure 16: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027

Figure 17: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027

Figure 18: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027

Figure 19: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027

Figure 20: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027

Figure 21: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027

Figure 22: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027

Figure 23: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027

Figure 24: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027

Figure 25: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027

Figure 26: North America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027 

Figure 27: North America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027 

Figure 28: North America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027 

Figure 29: North America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027 

Figure 30: Latin America Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)

Figure 31: Latin America Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)

Figure 32: Latin America Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)

Figure 33: Latin America Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)

Figure 34: Latin America Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 35: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 36: Brazil Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 37: Mexico Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 38: Rest of Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 39: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027

Figure 40: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027

Figure 41: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027

Figure 42: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027

Figure 43: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027

Figure 44: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027

Figure 45: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027

Figure 46: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027

Figure 47: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027

Figure 48: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027

Figure 49: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027

Figure 50: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027

Figure 51: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027

Figure 52: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027

Figure 53: Latin America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027 

Figure 54: Latin America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027 

Figure 55: Latin America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027 

Figure 56: Latin America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027 

Figure 57: Western Europe Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)

Figure 58: Western Europe Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)

Figure 59: Western Europe Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)

Figure 60: Western Europe Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)

Figure 61: Western Europe Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 62: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 63: Germany Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 64: United Kingdom Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 65: France Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 66: Italy Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 67: Spain Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 68: Nordic Region Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 69: Rest of Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 70: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027

Figure 71: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027

Figure 72: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027

Figure 73: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027

Figure 74: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027

Figure 75: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027

Figure 76: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027

Figure 77: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027

Figure 78: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027

Figure 79: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027

Figure 80: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027

Figure 81: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027

Figure 82: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027

Figure 83: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027

Figure 84: Western Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027 

Figure 85: Western Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027 

Figure 86: Western Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027 

Figure 87: Western Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027 

Figure 88: Eastern Europe Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)

Figure 89: Eastern Europe Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)

Figure 90: Eastern Europe Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)

Figure 91: Eastern Europe Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)

Figure 92: Eastern Europe Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 93: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 94: Russia Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 95: Poland Region Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 96: Rest of Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 97: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027

Figure 98: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027

Figure 99: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027

Figure 100: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027

Figure 101: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027

Figure 102: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027

Figure 103: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027

Figure 104: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027

Figure 105: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027

Figure 106: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027

Figure 107: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027

Figure 108: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027

Figure 109: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027

Figure 110: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027

Figure 111: Eastern Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027 

Figure 112: Eastern Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027 

Figure 113: Eastern Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027 

Figure 114: Eastern Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027 

Figure 115: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)

Figure 116: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)

Figure 117: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)

Figure 118: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)

Figure 119: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 120: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 121: China Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 122: India Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 123: Australia & New Zealand Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 124: ASEAN Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 125: Rest of Asia Pacific Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 126: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027

Figure 127: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027

Figure 128: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027

Figure 129: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027

Figure 130: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027

Figure 131: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027

Figure 132: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027

Figure 133: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027

Figure 134: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027

Figure 135: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027

Figure 136: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027

Figure 137: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027

Figure 138: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027

Figure 139: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027

Figure 140: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027 

Figure 141: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027 

Figure 142: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027 

Figure 143: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027 

Figure 144: Japan Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)

Figure 145: Japan Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)

Figure 146: Japan Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)

Figure 147: Japan Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 148: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 149: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027

Figure 150: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027

Figure 151: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027

Figure 152: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027

Figure 153: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027

Figure 154: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027

Figure 155: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027

Figure 156: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027

Figure 157: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027

Figure 158: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027

Figure 159: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027

Figure 160: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027

Figure 161: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027

Figure 162: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027

Figure 163: Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027 

Figure 164: Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027 

Figure 165: Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027 

Figure 166: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)

Figure 167: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)

Figure 168: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)

Figure 169: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)

Figure 170: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 171: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 172: GCC Countries Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 173: South Africa Region Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 174: Rest of Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 175: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027

Figure 176: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027

Figure 177: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027

Figure 178: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027

Figure 179: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027

Figure 180: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027

Figure 181: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027

Figure 182: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027

Figure 183: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027

Figure 184: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027

Figure 185: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027

Figure 186: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027

Figure 187: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027

Figure 188: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027

Figure 189: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027 

Figure 190: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027 

Figure 191: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027 

Figure 192: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027 

Figure 193: Global Anti-microbial/Anti-fungal Tests Market Y-o-Y Growth (%) 2017–2027, By Region

Figure 194: Global Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Region, 2017–2027 

Figure 195: Global Anti-microbial/Anti-fungal Tests Market Y-o-Y Growth (%) 2017–2027, By Test Type

Figure 196: Global Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027 

Figure 197: Global Anti-microbial/Anti-fungal Tests Market Y-o-Y Growth (%) 2017–2027, By Infection Type

Figure 198: Global Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027 

Figure 199: Global Anti-microbial/Anti-fungal Tests Market Y-o-Y Growth (%) 2017–2027, By End User

Figure 200: Global Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Anti-microbial/Anti-fungal Tests Market